Stock is my life
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
XOMA Limited (NASDAQ:XOMA) has the 8th highest upside potential in this segment of the market. Its upside is 274.5%. Its consensus target price is $8.80 based on the average of all estimates.
From the google finance site :
http://www.cnanalyst.com/2011/07/top-10-micro-cap-stocks-with-highest-upside-meg-eslr-ano-hev-trgl-ino-cytk-xoma-ands-nvax-jul-05-201.html
Yes That would be good - I bought at 1 and dumped at 1.32 in the morning . Will get back in at low 1s
Palatin Technologies (PTN) has been building a solid base in the 80 to 90 cent range. Palatin is a biotechnology company, based in New Jersey. These shares have traded in a range between 78 cents to $2.70 in the last 52 weeks. The 50 day moving average is 88 cents and the 200 day moving average is $1.14. PTN is developing a diverse range of products for the treatment of sexual dysfunction and other ailments such as congestive heart failure, obesity and metabolic syndrome. Palatin has a partnership agreement with drug giant AstraZeneca (AZN) whereby:
"Palatin is eligible for milestone payments totaling to $145 million, with up to $85 million contingent upon development and regulatory milestones and the balance on achievement of sales targets, together with the payment of royalties on sales of approved products. AstraZeneca assumed responsibility for product commercialization, product discovery and development costs, with both companies contributing scientific expertise in the research collaboration. In addition, Palatin is providing certain research services to AstraZeneca." (Read more about that agreement here).
Although Palatin is not well know amongst most retail investors, famed biotech investors "Deerfield Capital Management" and "BVF, Inc., (Biotechnology Value Fund)" are also heavily invested in this company. You can see that each of these investment companies own a about a 10% stake (for a total of almost 20%) in PTN here. Finally, PTN has at least one more exceptional biotech investor with a major stake of 3,250,000 shares (which is about 9.3% of the company), and that is Jeffrey R. Jay, MD, of Great Point Partners. Jay has an MBA from Harvard as well as an B.A./M.D., (magna cum laude and honors), from Boston University. You can read more about Great Point Partners, and his education and investment experience here. These three very savvy investors are a testament to the tremendous amount of upside in PTN shares.
Why Palatin shares could surge higher: Roth Capital just recently rated PTN a buy with a $5 price target. Palatin raised capital earlier this year, and now has a strong balance sheet with about $22 million in cash and a book value of about 46 cents. The high cash levels and partnership agreement with AstraZeneca for its obesity drug candidate takes a great deal of risk away for current investors. Palatin expects that current cash on hand will fund the company through the end of 2012, which should allow it to make significant clinical progress on its drug candidates and partnerships. You can see that statement and their latest quarterly report here.
A few days ago, Palatin announced that it was issued a U.S. Patent for a key component in its PL-3994 drug candidate. PL-3994 is a compound in development for treatment of asthma, heart failure and refractory hypertension. This new patent issuance could be the key to a future partnership agreement with a major pharma company. This stock looks like an opportunity to buy at the bottom, and with a handful of smart money investors owning a significant stake in PTN, the downside appears very limited and the upside from about 85 cents looks exceptional. If the price target of $5 is reached, investors buying now will gain about 600%. If the stock even reaches half of that price target, it would still be a home run. The ultimate target price remains to be seen, but what I do know is that shares are way too cheap now.
You can enter any symbol you want and see their history for regular stocks not just pinkies ! For eg BIDU or GOOG etc
Thank You
Now status has changed to "BUY Confirmed" at 0.0023 from Buy If !
http://americanbulls.com/StockPage.asp?CompanyTicker=STDF&MarketTicker=OTC&TYP=S
americanbulls website has been kind enough to start their cobverage of STDF with Buy if alert
0.01 Baby
I have 1.5M - Ready for the ride to penny
No it is not trading All of use are here for fun!
Good Jobs guys - Esp To all those holding at least 2.5M like me
at the 0.002 levels and below !
I know I have 1.5M and 1 M in two accounts at the 0.002 level ! Hurray for 0.003 and higher till 0.01 in a few days
Yep I am at 1.5M at 0.002 level
The guys who got it at 0.0017 level yesterday - Real smart ones!
Amen to that ! 0.011 easy !
STDF up 61% trying to break 0.003 after a ride to 0.015 2 days back
STDF trying to break 0.003s again after run upto 0.015 a few days back
I think so ! Have seen many graphs like this ! First shot is always the maximum (0.000 to 0.015) and then second time to 0.01 and after some time (may 1-2 months ) Zoom above 0.02
lol Just enjoy the ride to 0.01 in short term - The happiness in the board is enuf for ME !
Yep - as I said worry on RS only on scams - who do it all the time to unload shares - not on STDF - Loaded HEAVY at the 0.002 and below levels - I am feeling HEAVY !lol
Plus barchart dot com had a Strong Buy rating on this in spite of the huge drop from the 0.015 levels to 0.0015 - I am pretty confident of 0.01 target in near future (I am not worried about RS on good co, only on scams)
Agreed - I was just putting up a short term target(5-10 day) - not long term - I just loaded another 500K at these levels !
Agreed I recently made some good money from 0.02 to 0.08 on some other sub penny - Waiting for this to get another run to 0.01 from the 0.002 level
If co has good prospects - rs or FS do not matter - If it is a scam , RS is bad - Of course FS do not happen for bad cos ! eg BIDU had 10:1 split ! But good cos can have reverse split and go up !
I have followed the co and me too started buying the cheapies at 1.5M shares at 0.0022 average !
VPRO and SPPI fortunes tied together - and SPPI just touched $10 after great news from them - Go VPRO
CEO from MIT
Dr Datar holds a Ph. D in Bioprocess Technology from the Royal Institute of Technology of Stockholm, Sweden and Post-Doctorate in Biochemical Engineering from the Massasuchetts Institute of Technology (MIT). He has graduated as Biochemist / Chemist from the University of Pune, India and has Post-Graduate studies in Chemical Engineering from the University of Manchester, United Kingdom.
Opposite effect
Now they raise prices to 0.0004 from 3 on 10K - Normally don't they do these kins of things in the negative direction ?
LETS GO PIHN 0.0005
PIHN Breakout on 113M Vol
PIHN - 0.0005 Rreached on 133M Vol (Av Vol 40M)
PIHN Vol Surge is HUGE
PIHN HUGE HUGE Vol
PIHN - HUGE Vol
PIHN Vol Surge...
PIHN 100M vol all of a sudden
PIHN up to 0.0007 today...
PIHN up...
Any PIHN heads here ?
YA Baby Lets all be PIHN heads...